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Research Article
Arsenate and Dimethylarsinic Acid in Drinking Water
did not Affect DNADamage Repair in Urinary Bladder
Transitional Cells or Micronuclei in BoneMarrow
Amy Wang,1* Andrew D. Kligerman,2 Steven D. Holladay,1
Douglas C.Wolf,2 and John L. Robertson1
1Department of Biomedical Sciences and Pathobiology, Virginia Maryland
Regional College of Veterinary Medicine, Virginia Polytechnic Institute and
State University (Virginia Tech), Blacksburg, Virginia 24061
2Environmental Carcinogenesis Division, National Health and Environmental
Effects Research Laboratory, Office of Research and Development,
U.S. Environmental Protection Agency (U.S. EPA), Research Triangle Park,
North Carolina 27711
Arsenic is a human skin, lung, and urinary blad-
der carcinogen, and may act as a cocarcinogen
in the skin and urinary bladder. Possible modes of
action of arsenic carcinogenesis/cocarcinogene-
sis include oxidative stress induction and inhibition
of DNA damage repair. We investigated the
effects of arsenic in drinking water on DNA dam-
age repair in urinary bladder transitional cells
and on micronucleus formation in bone marrow.
F344 rats were given 100 ppm arsenate [As(V)]
or dimethylarsinic acid [DMA(V)] in drinking
water for 1 week. The in vivo repair of cyclophos-
phamide (CP)-induced DNA damage resulting
from a single oral gavage of CP, and the in vitro
repair of hydrogen peroxide (H2O2)- or formalde-
hyde-induced DNA damage, resulting from add-
ing H2O2 or formaldehyde into cell medium, were
measured by the Comet assay. DMA(V) effects
were not observed on either CP-induced DNA
damage induction or on DNA repair. Neither
DMA(V) nor As(V) increased the H2O2- or formal-
dehyde-induced DNA damage, and neither
inhibited the repair of H2O2-induced DNA dam-
age. Neither DMA(V) nor As(V) increased the
micronucleus frequency, nor did they elevate
micronucleus frequency resulting from CP treat-
ment above the level observed by the treatment
with CP alone. These results suggest that arsenic
carcinogenesis/cocarcinogenesis in the urinary
bladder may not be via DNA damage repair inhi-
bition. To our knowledge this is the first report of
arsenic effects on DNA damage repair in the uri-
nary bladder. Environ. Mol. Mutagen. 50:760–
770, 2009. Published 2009 by Wiley-Liss, Inc.*
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INTRODUCTION
Arsenic, a human carcinogen, is a widely distributed
natural metalloid, and is used in man-made products such
as herbicides. The primary arsenic exposure to the general
population is through drinking water. Arsenic, namely
inorganic arsenic in the forms of arsenite [As(III)] and ar-
senate [As(V)], in drinking water increases the incidences
of cancers in lung (squamous and small cell carcinoma)
[Guo et al., 2004], skin (Bowen’s disease, basal and squa-
mous cell carcinoma) [Guo et al., 2001], and urinary blad-
der (transitional cell carcinoma) [Chiou et al., 2001]. In
addition, arsenic may act as a cocarcinogen in the urinary
bladder (with cigarette smoking) [Chiou et al., 2001] and
skin (with UV light exposure) [Rossman et al., 2004].
The study of arsenic carcinogenesis is complicated. The
metabolism of inorganic arsenic into various organic
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arsenicals, tissue-specific distribution of the arsenicals, and
arsenical-dependent toxicities and mechanisms by which
adverse effects are mediated, are just a few factors that
need to be considered [Kligerman and Tennant, 2006;
Wang et al., 2007b]. For example, humans and rodents
metabolize As(V) into As(III), and into monomethylarsonic
acid [MMA(V)], monomethylarsonous acid [MMA(III)],
dimethylarsinic acid [DMA(V)], and dimethylarsinous acid
[DMA(III)]. In mice gavaged with As(V), DMA(V) con-
centrations were highest in the urinary bladder and lung,
but inorganic arsenic concentrations were highest in the
kidney [Hughes et al., 2003]. Trivalent arsenicals are more
toxic than their pentavalent counterparts, with MMA(III)
and DMA(III) being the most toxic. In humans, increased
incidences of urinary bladder cancer were seen after expo-
sure to inorganic arsenic, but in laboratory animals, signifi-
cantly increased incidences of urinary bladder cancer have
only been observed in F344 rats exposed to DMA(V)
[Wang et al., 2002]. Rats can tolerate much higher doses of
inorganic arsenic than humans, and this is at least partially
because of the binding of DMA(III) to red blood cells in
rats [Lu et al., 2004; Cohen et al., 2007].
Several modes of action of arsenic carcinogenesis have
been proposed. They include (1) oxidative stress induc-
tion, (2) DNA damage repair inhibition, (3) signal trans-
duction pathway modulation, (4) cell proliferation
increases (altered growth factors and regenerative prolifer-
ation), (5) induction of chromosomal abnormalities, and
(6) DNA methylation alteration [Kitchin, 2001; Schoen
et al., 2004]. These possible modes of action are not
mutually exclusive. For example, arsenic-induced oxida-
tive stress can lead to chromosomal abnormalities [Ho
et al., 2000]. Furthermore, the mode of action of arsenic
carcinogenesis is believed to be tissue-specific. For
instance, arsenic may have a different mode of action in
the bladder than in other organs because of the mixture of
arsenic metabolites in the urine [Rossman, 2003].
Because arsenic is reported to be a strong comutagen
and cocarcinogen, it has long been hypothesized that ar-
senic interferes with DNA damage repair and therefore
enhances the mutagenicity and carcinogenicity of DNA-
damaging agents [Vogt and Rossman, 2001; Rossman
et al., 2004]. Arsenic-inhibited DNA damage repair has
been reported in cultured skin and lung cells [Schwerdtle
et al., 2003; Wu et al., 2005], but arsenic effects on DNA
repair have not been studied in urinary bladder cells.
Decreases in expression of DNA repair genes were
observed in cultured cells exposed to noncytotoxic con-
centrations of arsenic [Hartwig et al., 2003; Clewell et al.,
2006]. Decreased DNA repair gene expression occurred
concurrently with increased expression of oxidative stress
response genes [Hamadeh et al., 2002], suggesting
decreased DNA repair of arsenic-induced oxidative dam-
age. Recently, decreases in DNA damage repair and DNA
repair gene expression were observed in lymphocytes col-
lected from arsenic-exposed humans [Andrew et al., 2003;
Andrew et al., 2006].
The view that decreased DNA damage repair may con-
tribute to urinary bladder cancer risk is supported by
decreases in DNA repair in carcinogen-treated bladder
cells compared to normal cells [Yoshimi et al., 1989].
Also, decreased expression of DNA repair genes, but not
necessarily activity, was associated with bladder cancer
progression [Kawakami et al., 2004; Korabiowska et al.,
2004]. Arsenic-decreased DNA damage repair in urinary
bladder cells could explain, at least partially, the higher
bladder cancer risk in smokers as compared to non-
smokers in the arsenic-exposed population [Chiou et al.,
2001] because cigarettes contain mutagenic components,
and the urine of smokers is more mutagenic than the
urine of nonsmokers [Bowman et al., 2002].
Studies of F344 rats exposed to DMA(V) in diet or water
[Cohen et al., 2001; Wei et al., 2002] provide evidence for
the following mode of action of DMA(V)-induced bladder
cancer [Sams et al., 2007]. First, DMA(V) is reduced to
DMA(III), and DMA(III) causes cytotoxicity in the urothe-
lium [Cohen et al., 2001, 2002; Sams et al., 2007]. Conse-
quently, regenerative proliferation occurs and leads to
hyperplasia and eventually bladder tumors. These events
are plausible in humans, but do not exclude other modes of
action, such as oxidative stress [Wei et al., 2005], chromo-
somal abnormalities [Moore et al., 2002], or DNA damage
repair inhibition.
One of the purposes of the present study was to investigate
if 1-week oral exposure to DMA(V) or As(V) inhibits DNA
damage repair in urinary bladder transitional cells, a target
cell of arsenic carcinogenesis. DMA(V) was chosen because
it can induce bladder cancer in rats, and As(V) was investi-
gated as it is one of the common forms of arsenic that
humans ingest in drinking water. Three types of DNA dam-
age repair were studied: (1) in vivo repair of cyclophospha-
mide (CP)-induced DNA damage, which includes DNA
strand breaks and DNA-DNA crosslinks, (2) in vitro repair
of hydrogen peroxide (H2O2)-induced DNA damage, which
is mainly oxidative DNA damage, and (3) in vitro repair of
formaldehyde-induced DNA-protein crosslinks.
We also investigated whether in vivo exposure of
DMA(V) or As(V) increases micronucleus (MN) frequen-
cies in the bone marrow. A MN is the result of either chro-
mosomal breakage or chromosome malsegregation.
Humans exposed to arsenic through drinking water showed
increased MN frequencies in cells of various tissues, and
MN have been suggested as a biomarker of arsenic exposure
[Moore et al., 1997; Feng et al., 2001; Tian et al., 2001;
Basu et al., 2004; Chakraborty et al., 2006].
MATERIALS ANDMETHODS
Chemicals
Arsenic [IARC, 2004], CP [IARC, 1987], and formaldehyde [IARC,
2006] are human carcinogens. Beuthanasia and sodium hydroxide
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(NaOH) are also hazardous to human health and should be handled with
care.
For animal treatments, DMA(V) [(CH3)2As(O)OH] (CAS no. 75-60-
5O), purity > 99%, was purchased from Sigma, St. Louis, MO. As(V) in
the form of sodium hydrogen arsenate heptahydrate [Na2HAsO4  7H2O]
(CAS no. 10048-95-0), purity > 98.5%, was also from Sigma. CP (CAS
no. 6055-19-2), purity > 98%, was purchased from MP Biomedicals,
Aurora, OH. Isoflurane was from Abbott Animal Health, North Chicago,
IL, and Beuthanasia was obtained from Schering-Plough Animal Health
Corporation, Union, NJ.
For terminal surgeries to harvest cells, Isoflurane (CAS no. 26675-46-7)
was purchased from Abbott Animal Health, North Chicago, IL. Beuthana-
sia [390 mg pentobarbital sodium (barbituric acid derivative) and 50 mg
phenytoin sodium per ml of Beuthanasia] (CAS no. 8024-20-2) was
obtained from Schering-Plough Animal Health Corporation, Union, NJ.
For the Comet assay, Williams’ medium E, trypsin, ethylenediamine-
tetraacetic acid disodium salt dihydrate (Na2EDTA), dimethyl sulfoxide
(DMSO), NaOH, and Trizma base were purchased from Sigma, as was
formaldehyde (36.5–38%). Fetal bovine serum (FBS) was from Cambrex
Bio Science Walkersville, Walkersville, MD and Atlanta Biologicals,
Lawrenceville, Ga. H2O2 was from Fisher Scientific, Suwanee, Georgia.
Proteinase K (Catalog No. 25530-049), L-glutamine (Gibco), and SYBR
gold (Molecular Probe) were obtained from Invitrogen, Grand Island,
NY. Comet LMAgarose (low melting temperature agarose), Comet Lysis
Solution, and FLARE slides (each slide has three sample loading areas
precoated with agarose ) were purchased from Trevigen, Gaithersburg,
MD. Ethanol (200 proof ethyl alcohol) was from AAPER, Shelbyville,
KY.
For the MN assay, FBS (Catalog no. BW14-501C) and methanol were
from Fisher Scientific, and Na2EDTA was from Sigma. Acridine orange
(Molecular Probe) was purchased from Invitrogen.
Animals and Animal Care
Animal use and procedures were approved by the Virginia Tech Insti-
tutional Animal Care and Use Committee for Animals Used in Research
and Testing before the initiation of the study.
Female F344 rats, age 5–9 weeks old, were purchased from Harlan
Teklad (Madison, WI). F344 rats are the only identified laboratory ani-
mals that develop urinary bladder transitional cell carcinoma from ar-
senic in drinking water [Wei et al., 2002] or diet [Arnold et al., 2006].
Females were chosen because their urinary bladders are more susceptible
to arsenic toxicity than males [Arnold et al., 1999; Shen et al., 2006].
All rats were quarantined and acclimated for at least 2 weeks. Polycar-
bonate shoebox-style cages with Alpha Dry bedding (Shepherd Specialty
Papers, Watertown, TN) were used to minimize dust, because both
DMA(V) and CP metabolites were excreted in the urine [de Jonge et al.,
2005; Shen et al., 2006]. The rats were housed in a temperature con-
trolled room with a 12-hr light/dark cycle, and single-housed at least 1
week before the beginning of in vivo dosing. Teklad 2018 SC diet
(Harlan Teklad, Madison, WI) and tap water in plastic water bottles with
stainless steel sipper tubes with stoppers were available ad libitum.
Animal Treatments and Experimental Design (See Table I)
The experiment consisted of eight animal treatment groups, estab-
lished to provide data to test the response to three types of DNA dam-
age. With the exception of the negative control groups G, with four rats,
and H, with three rats, all other groups consisted of six rats (Table I).
The number of animals per group was determined based on preliminary
studies. Rats in Groups G and H (tap water and then 1 or 5 days of re-
covery) were expected to have the same levels of DNA damage and
were designed to be pooled for the in vitro repair study to minimize the
number of animals. Animals were treated via drinking water for 7 days
with either 100 ppm DMA(V) [Groups A through D], or 100 ppm As(V)
[Group I ]. The concentration of DMA(V) was chosen because of the
increase in bladder transitional cell carcinoma in rats exposed to 100
ppm DMA(V) in 2 year exposure studies [Wei et al., 1999; Arnold
et al., 2006], and the As(V) concentration was chosen to provide com-
parison to DMA(V) exposure. A single oral gavage of CP (11.75 mg
CP/kg BW, equivalent to 1/8 LD50) was given at the end of 7-day expo-
sure to DMA(V), and animals were allowed to recover for either 1 day
[Group A] or 5 days [Group B] before the terminal surgery to collect
urinary bladder cells and bone marrow. During the surgery, the rat was
anesthetized by isoflurane inhalation, and the urinary bladder was treated
and removed (see below Comet assay with transitional cells to detect
DNA damage and repair and [Wang et al., 2007a]). The rat was then eu-
thanized with an intracardiac injection of Beuthanasia, and the bone mar-
row was harvested. Previous studies showed that 1 week exposure to
100 ppm DMA(V) did not affect food consumption, water consumption,
or body weight in F344 rats [Cohen et al., 2001]. The dose of CP (1/8
LD50) was determined by preliminary experiments to be noncytotoxic to
urinary bladder transitional cells based on trypan blue exclusion assay;*
furthermore, CP-induced DNA damage in transitional cells was detected
24 hr after the gavage of CP, and was not observed 5 days later as meas-
ured by alkaline Comet assay (unpublished data). Solutions of DMA(V)
(100 ppm) and As(V) (100 ppm) were made weekly with tap water to
Environmental and Molecular Mutagenesis. DOI 10.1002/em
TABLE I. Study Design All rats were given tap water, 100
ppm DMA(V), or 100 ppm As(V) in drinking water for 7
days. At the end of the 7-day treatment, certain rats received
a single oral gavage of CP (Groups A, B, E, and F). Rats
were given tap water during the recovery period. Urinary
bladder transitional cells collected from rats in Groups A, B,
D, E, and F received no additional treatment. Portions of
transitional cells collected from rats in Groups C, G, H, and
I were treated with H2O2 or formaldehyde for 10 minutes on
ice, and then some cells were allowed to recover in medium
without H2O2 or formaldehyde at 378C for 4 h. For measure-
ments of MN and polychromatic erythrocytes frequencies,
bone marrow were collected from negative control rats
(Groups G and H) and rats exposed to DMA(V) 1CP
(Group A), DMA(V) (Group C), CP (positive control, Group
E), or As(V) (Group I) 1 day after the last in vivo dosing.
*indicates the group from which bone marrow was collected
after in vivo dosing and in vivo recovery (without in vitro
dosing or recovery)
Group
For in vivo repair For in vitro repair
In vivo
dosing
In vivo
Recovery
(days)
In vitro
dosing
In vitro
Recovery
(hrs)
A* DMA(V) 1 CP 1 — —
B DMA(V) 1 CP 5 — —
C* DMA(V) 1 H2O2, Formaldehyde 0, 4
D DMA(V) 5 — —
E* Tap water 1 CP 1 — —
F Tap water 1 CP 0 — —
G* Tap water 1 H2O2, Formaldehyde 0, 4
H* Tap water 5 H2O2, Formaldehyde 0, 4
I* As(V) 1 H2O2, Formaldehyde 0, 4
*While trypan blue exclusion assay is widely used and often recom-
mended for viability checks before the Comet assay, it is a less rigorous
estimation of cell survival than the clonal survival assay [Komissarova
et al., 2005]. Therefore it is possible that the treatment [CP, H2O2, form-
aldehyde, or DMA(V)] could have caused a lower viability when meas-
ured in more sensitive assays, such as the clonal survival assay, than in
the trypan blue exclusion assay.
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mimic human water sources [Huff et al., 1998] and stored at room tem-
perature. The CP solution (23.5 mg/10 ml deionized water) was made
weekly and stored at 48C in the dark to minimize degradation [Beijnen
et al., 1992].
The experiment was performed in six blocks, based on our capacity
for surgery and the number of commensurate Comet assays that could be
performed. Each block included one rat from groups A to F and I, and
one rat from either Group G (blocks 2, 4, 6) or H (blocks 1, 2, 3, 5),
with the exception that block 2 included rats from groups G and H. After
quarantine and acclimation, rats were assigned to one of the six blocks
by age, so all rats in a block were the same age. Within each block, rats
were randomly assigned to animal treatment groups.
To study DMA(V) effects on in vivo repair of CP-induced DNA dam-
age, urinary bladder transitional cells were collected after animal treat-
ments in all Groups and subjected to the alkaline Comet assay based on
previously developed methods [Wang et al., 2007a]. Groups G and H
(tap water) were for background DNA damage at each time point, and
Groups E and F (tap water 1 CP, 1 or 5 day recovery) provided DNA
repair control data. Groups A and B [DMA(V) 1 CP, 1 or 5 day recov-
ery] were our test groups. Groups C and D [DMA(V), 1 or 5 day recov-
ery] and Group I [As(V), 1 day recovery] provided information on the
genotoxicity of selected arsenic treatments.
To study the effects of DMA(V) and As(V) on in vitro repair of
DNA damage, transitional cells were collected from rats exposed to
DMA(V) or As(V) with 1 day recovery (Groups C and I, test groups)
and rats exposed to tap water (Groups G and H, negative control). Col-
lected transitional cells were treated with H2O2 or formaldehyde (in
vitro dosing) to induce DNA damage, and DNA damage levels were
measured immediately after in vitro dosing, or after 4 hr of in vitro re-
covery. Both the H2O2 and formaldehyde in vitro dosings were in non-
cytotoxic, but genotoxic ranges. H2O2-induced DNA damage was meas-
ured by the standard alkaline Comet assay, and formaldehyde-induced
DNA damage was measured by the alkaline Comet assay with and
without Proteinase K for detecting DNA-protein crosslinks [Wang
et al., 2007a].
To study DMA(V) and As(V) effects on MN frequencies, bone
marrow was collected from rats exposed to DMA(V), As(V), or
DMA(V)1CP after a 1-day recovery period (Groups C, I and A), to tap
water (Groups G and H, negative control), and to tap water 1 CP with a
1-day recovery period (Group E, positive control). Comparing bone mar-
row from rats exposed to DMA(V) or As(V) (Groups C and I) to bone
marrow from rats exposed to tap water (Groups G and H) provided data
on whether DMA(V) or As(V) in drinking water induced MN, while
comparing bone marrow from rats exposed to DMA(V) or DMA(V)1CP
(Groups C and A) provided data on whether DMA(V) increased CP-
induced MN.
Comet Assay With Transitional Cells to Detect DNA
Damage and Repair
Methods for selective harvest of viable urinary bladder transitional
cells and detailed protocols for the Comet assay in these cells were pre-
viously developed [Wang et al., 2007a]. To prevent UV light-induced
DNA damage, all procedures (except after dehydration by ethanol and
before staining by SYBR gold) were done under UV-free light sources.
Briefly, the bladder was rinsed, inflated with a solution containing tryp-
sin and Na2EDTA while the rat was under anesthesia. The inflated blad-
der was then separated from the rat and incubated for 30 min before
being gently scraped to remove transitional epithelium. The transitional
cells were resuspended in Williams’ E medium supplemented with 10%
FBS and 2 mM L-glutamine (W1S), centrifuged, and tested by trypan
blue exclusion assay for an indicator of cell viability.
Transitional cells collected from rats in Groups C, G, H, and I were
divided into three aliquots. These were treated with either PBS (negative
control), 100 mM H2O2, or 5 mM formaldehyde for 10 min on ice (in
vitro dosing). Half the cells from each in vitro dosing were resuspended
in W1S and incubated at 378C for 4 hr to recover from the H2O2, form-
aldehyde, or PBS (negative control) treatments before being subjected to
the Comet assay. Formaldehyde-treated and untreated cells were sub-
jected to the alkaline Comet assays with and without Proteinase K.
H2O2-treated and untreated cells were subjected to the standard alkaline
Comet assay. Transitional cells collected from rats in groups A, B, D, E,
and F were treated with PBS for 10 min on ice and then subjected to the
standard alkaline Comet assay. All samples were tested for cell viability.
Cells were resuspended in LMAgarose at 378C and were loaded onto
FLARE slides. For the standard alkaline Comet assay, the cells were
lysed for 1 hr, and the DNA was unwound in alkaline solution (pH >13)
for 30 min. Electrophoresis with alkaline solution was performed at 40
V (1 V/cm) and 300 mA for 30 min. For alkaline Comet assays with
and without Proteinase K, the lysis was overnight, and slides were incu-
bated with Proteinase K (1 mg/ml in TE buffer, pH 8.0) or TE buffer for
2 hr at 378C. The unwinding step was 20 min, and electrophoresis was
at 32 V (0.8 V/cm) and 300 mA for 30 min.
After electrophoresis, slides were neutralized and dried. Slides were
randomized, stained with SYBR gold, and scored by a person without
knowledge of treatments using image-analysis software Komet 5.5
(Kinetic Imaging, Liverpool, UK). For each sample, 100 Comets were
scored for each Comet assay condition. The percentage of DNA in the
tail was chosen as the indicator of DNA migration in Comet assays.
DNA-protein crosslinks were calculated by subtracting the percentage of
DNA in the tail without Proteinase K from the percentage of DNA in
the tail with Proteinase K.
BoneMarrowMN
MN frequencies were measured in the bone marrow of rats exposed to
water (Groups G and H), and all rats that had 1 day recovery time after
chemical exposure (groups A, C, E, and I). The left femur was removed
from the euthanized rat, and both ends (epiphyses) of the femur were
removed. The bone marrow was flushed with FBS containing 25 mM
EDTA, which was added to prevent cell clumping. Cells were pelleted
by centrifugation at 220 g for 5 min at room temperature and resus-
pended with 1 ml FBS containing 25 mM EDTA. A bone marrow
smear was prepared on a glass slide by spreading a 5 ll cell suspension
behind a second slide. Three smears were made from each rat. The
smears were air dried, fixed with 100% methanol for 10 min, and air
dried again. Slides were coded, stained with acridine orange, and scored
using a fluorescent microscope. Two slides from the same rat were
examined by two people independently without knowledge of treatments.
Each person scored 1,000 polychromatic erythrocytes (reticulocytes;
immature erythrocytes) per slide for MN frequencies, and 2,000 erythro-
cytes per slide for the percentage of polychromatic erythrocytes (poly-
chromatic erythrocytes among the total erythrocyte population).
Statistical Analysis
Results are expressed as the mean 6 standard deviations, and P <
0.05 was considered significant. All data were tested using SAS 9.1.3
from SAS Institute, Cary, NC, except the percentages of polychromatic
erythrocytes, which were tested using Statgraphics1 Plus 5.1 statistical
package from Manugistics, Rockville, MD.
For testing in vivo repair of CP-induced DNA damage, analysis of
variance (ANOVA) and the Tukey posthoc test were used on arcsine
transformed percentages of DNA in the tail in Comet assays. For testing
in vitro repair of H2O2-induced DNA damage ANOVA was used on
untransformed percentages of DNA in the tail in Comet assays. For test-
ing in vitro repair of formaldehyde-induced DNA damage, the arcsine
transformed percentages of DNA in the tail in Comet assays were tested
by ANOVA and contrast test.
For MN frequencies, ANOVA and the Tukey posthoc test were used
on arcsine transformed data. Percentages of polychromatic erythrocytes
Environmental and Molecular Mutagenesis. DOI 10.1002/em
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in bone marrow were subjected to ANOVA and Duncan’s multiple com-
parison post test.
RESULTS
Cell Viability of Urinary Bladder Transitional Cells
After the designated animal treatments (Table I), transi-
tional cells collected from all rats had higher than 60%
viabilities as measured by the trypan blue exclusion
assay*, with the exception of cells from one rat each in
Groups A (26% viability) and I (55% viability). The low
viability (26%) may have been because of insufficient
trypsin and EDTA treatment during the cell collection
process, and samples with less than 60% viability were
excluded. Overall, the viability results suggested that the
animal treatments were at worst only mildly cytotoxic to
the bladder.
While transitional cells collected from rats in Groups
A, B, D, E, and F were not further treated in vitro, cells
collected from rats in Groups C, G, H, and I were treated
with H2O2 or formaldehyde and then underwent 0 or 4 hr
of 378C incubation for recovery. Cells collected from
Groups C, G, H or I showed higher than 70% viability
after the H2O2 or formaldehyde treatments, indicating
that these in vitro dosings were essentially noncytotoxic.
Furthermore, most cells had greater than 70% viability
after a 4-hr recovery, with only a few samples with 53 to
67% viability.
DNADamage Repair in Urinary Bladder Transitional Cells
InVivo CP-Induced Damage
None of the in vivo dosing regimens significantly
increased DNA migration in the alkaline Comet assay af-
ter a 1-day in vivo recovery (Groups A, C, E, G, and I)
(Fig. 1), indicating either that none of the in vivo expo-
sures to DMA(V), DMA(V)1CP, H2O1CP, or As(V)
increased DNA damage or that the damage was repaired
within 24 hr. There was also no difference in DNA
migration in the Comet assay between 1 and 5-day recov-
eries within each in vivo dosing, indicating either no
delayed presence of DNA damage or a complete repair of
DNA damage within 24 hr.
InVitro H2O2-Induced Damage
In the test of whether DMA(V) or As(V) affects oxida-
tive DNA damage repair, cells collected from rats in
Groups C, G, H, and I [in vivo dosing of DMA(V),
As(V), or tap water] were tested for the repair of in vitro
H2O2-induced DNA damage. Cells were treated with or
without H2O2, after which half the cells were allowed to
recover in H2O2-free medium for 4 hr before being sub-
jected to the standard alkaline Comet assay (Fig. 2).
In the test of whether H2O2 increased DNA damage
and whether any in vivo dosing increased cellular sensi-
tivity to H2O2 genotoxicity, DNA migrations in the
Comet assay from all samples with 0 hr in vitro recovery
(with or without H2O2 treatment) were tested by an
ANOVA. As expected, H2O2 significantly increased DNA
damage. None of the 7-day in vivo exposures to DMA(V)
or As(V) significantly affected the cellular sensitivity to
H2O2 genotoxicity.
In the test of whether repair of H2O2-induced DNA
damage was affected by in vivo exposure to As(V) or
DMA(V), DNA migrations in the Comet assay from sam-
ples treated with H2O2 after 4 hr in vitro recovery were
subjected to an ANOVA. There were no significant in
vivo dosing effects, indicating DNA damage levels after 4
hr of recovery were the same among H2O2-treated cells
Environmental and Molecular Mutagenesis. DOI 10.1002/em
Fig. 1. DNA migration in the alkaline Comet assay without Proteinase
K in the urinary bladder transitional cells was the same among rats
exposed to in vivo dosings of water (negative control), CP, DMA(V),
DMA(V)1CP, or As(V). DNA migration level after 5-day recovery fol-
lowing the in vivo dosing was not different from the DNA migration
level after 1-day recovery of the same in vivo dosing. The results
showed that neither DMA(V) nor As(V) increased DNA damage in tran-
sitional cells, or that the damage was repaired within 1 day. Each dia-
mond indicates the average percentage of DNA in the ‘‘Comet tail’’ for
each group, and the error bar indicates standard deviation.
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collected from rats exposed in vivo to DMA(V), As(V),
or tap water. These data showed that no effects from 7-
day in vivo exposures to DMA(V) or As(V) on the repair
of in vitro H2O2-induced DNA damage were observed.
InVitro Formaldehyde-Induced Damage
Cells collected from rats in Groups C, G, H, and I
were also tested for repair of in vitro formaldehyde-
induced DNA-protein crosslinks. Cells were treated with
or without formaldehyde, after which half the cells were
allowed to recover in formaldehyde-free medium for 4 hr.
Comet assays with and without Proteinase K were per-
formed, and the results are shown in Figure 3. The bulky
protein in DNA-protein crosslinks decreases DNA migra-
tion rate in Comet assay, so cells with DNA-protein
crosslinks show decreased DNA migration in Comet
assay. Proteinase K removes protein and frees the previ-
ously protein-crosslinked DNA to migrate at a regular
rate, but Proteinase K does not affect DNA or DNA-DNA
crosslinks. Therefore, the differences in DNA migration
in Comet assays with and without Proteinase K provide
an indication of DNA-protein crosslink levels. In our
study, the effects of formaldehyde treatment (in vitro dos-
ing), in vitro recovery, and Proteinase K treatment were
significant, indicating that these treatments affected DNA
migration in Comet assays through the induction of DNA-
protein crosslinks, and their subsequent removal by Pro-
teinase K. However, the effects of in vivo dosing with the
arsenicals were not statistically significant, indicating that
neither As(V) nor DMA(V) affected the DNA migration
in Comet assays.
In cells collected from rats exposed to tap water
(Groups G and H), formaldehyde significantly decreased
DNA migration when no Proteinase K was used, but not
when Proteinase K was used at 0 hr. This indicated that
DNA-protein crosslinks were induced by formaldehyde.
After 4 hr of recovery, formaldehyde-treated cells from
rats exposed to tap water did not exhibit significant differ-
ences in DNA migrations in Comet assays with and with-
out Proteinase K, indicating the lack of DNA-protein
crosslinks. Because DNA migration in the Comet assays
was also significantly decreased within 4 hr when no Pro-
teinase K was used, it can be inferred that the observed
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Fig. 2. The repair of in vitro H2O2-induced DNA damage in urinary
bladder transitional cells was not affected by DMA(V) or As(V) expo-
sures through drinking water. Transitional cells from rats exposed to 100
ppm DMA(V) (Group C), 100 ppm As(V) (Group I) in drinking water
for 7 days had the same levels of DNA damage as cells from rats
exposed to tap water (Groups G and H). After in vitro exposure to
H2O2, DNA damage levels in all four groups were the same. * indicates
significant difference from PBS-treated cells at the same recovery time.
[Color figure can be viewed in the online issue, which is available at
www.interscience.wiley.com.]
Fig. 3. DNA migration in formaldehyde-treated and control urinary
bladder transitional cells after 0 hr (a) or 4 hr (b) of recovery. The ani-
mal treatments were the same as in Figure 2. In negative controls
(Groups G and H), formaldehyde decreased DNA migration in the
Comet assay without Proteinase K at both 0- and 4-hr recoveries. When
Proteinase K was used there were significant increases in DNA migration
in the Comet assay at 0-hr recovery. This suggested the presence of
DNA-protein crosslinks after formaldehyde treatment. In DMA(V)- and
As(V)-treated rats (Groups C and I), in vitro formaldehyde caused
decreases in DNA migration in the Comet assay without Proteinase K,
but these did not reach statistical significance. *1 indicates a significant
difference from PBS-treated cells (same Comet assay, at the same recov-
ery time), *2 indicates a significant difference from Comet assays with
Proteinase K (same sample, at the same recovery time), *3 indicates a
significant difference from the same sample in the same Comet assay
test at 0-hr recovery. [Color figure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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decrease in DNA-protein crosslinks was due at least par-
tially to the repair of strand breaks, alkaline labile sites,
or incomplete excision repair sites.
In the cells collected from rats exposed to As(V) or
DMA(V), formaldehyde-induced decreases in DNA
migration in Comet assays without Proteinase K, and
increases after Proteinase K treatment did not reach the
0.05 level of significance. However, the same trends
(slight decreases in DNA migration in formaldehyde-
treated cells as compared to PBS-treated cells, and slight
increases in DNA migration by Proteinase K treatment in
formaldehyde-treated cells as compared to no Proteinase
K treatment) were seen in those animals drinking tap
water. The exact reasons are unknown but may be
because of the slightly higher variances seen in the ani-
mals on DMA(V) and As(V).
MNand Polychromatic Erythrocytes in BoneMarrow
The MN frequencies were increased in bone marrow
collected from rats exposed to CP (Group E; positive con-
trol) or DMA(V)1CP (Group A) as compared to the MN
frequencies in those rats exposed to tap water (Groups G
and H; negative control) (Fig. 4). The MN frequencies
were not significantly different between samples from rats
exposed to DMA(V)1 CP vs. CP alone (Groups A and
E), indicating an absence of additive or synergetic effects
between DMA(V) and CP on MN formation. MN fre-
quencies in the bone marrow from rats exposed to
DMA(V) or As(V) (Groups C and I) were not signifi-
cantly different from those of rats exposed to tap water
(Groups G and H). Both the exposures to CP (positive
control) and DMA(V)1CP decreased erythrocyte produc-
tion, based on the significantly lower percentages of poly-
chromatic erythrocytes in bone marrow collected from
rats exposed to CP or DMA(V)1CP (Groups E or A,
respectively) as compared to the negative control (Groups
G and H) (Fig. 5). Neither DMA(V) nor As(V) affected
erythrocyte production in rats.
DISCUSSION
Arsenic inhibition of DNA damage repair has been
reported in various cell types, but it has not been previ-
ously studied in urinary bladder transitional cells, a major
target of arsenic carcinogenesis/cocarcinogenesis. In the
present study, we measured arsenic effects on in vivo and
in vitro exposures to DNA damaging agents in transitional
cells freshly collected from rats. The use of newly har-
vested transitional cells provided several benefits in accu-
rately assessing arsenic effects compared to studies using
whole bladders or bladder cell lines. First, arsenic carci-
nogenesis is cell-type specific, so the use of only transi-
tional cells avoids potentially misleading information
from other types of cells in the bladder. Secondly, urothe-
lial cell lines, such as HUC-1 and UROtsa, may have
inactivated p53 protein because of transformation with
SV40 large T antigen [Rossi et al., 2001; Su et al., 2006].
Studies showed that cells without functional p53 proteins
were more sensitive to arsenic and have different cellular
responses than cells with functional p53 [Kircelli et al.,
2007]. Rats used in our study have normal expression of
wild-type p53, and the status of p53 was not tested in the
primary cell cultures of urinary bladder transitional cells.
The present study showed that urinary bladder transitional
cells from rats exposed to DMA(V) through drinking
water did not show altered cellular sensitivity to in vivo
CP- or in vitro formaldehyde-induced DNA damage, or
reduced repair of in vitro H2O2-induced DNA damage.
Similarly, transitional cells from rats exposed to As(V)
through drinking water did not show altered sensitivity to
in vitro formaldehyde-induced DNA damage or reduced
repair of in vitro H2O2-induced DNA damage. Further-
more, neither DMA(V) nor As(V) exposure induced MN
in the bone marrow, and DMA(V) did not increase CP-
induced MN.
Various DNA damage repair pathways are responsible
for the repair of specific types of DNA damage. Previ-
ously reported arsenic-inhibited DNA damage repair
pathways include (1) base excision repair (BER) [Le and
Weinfeld, 2004], (2) nucleotide excision repair (NER)
[Wu et al., 2005; Andrew et al., 2006], and (3) nonhomol-
ogous end joining or homologous recombination. The
mismatch repair pathway was probably not affected by ar-
senic because microsatellite instability was not altered in
DMA(V)-induced rat bladder transitional cell carcinoma
[Wei et al., 2002]. Our observation that neither DMA(V)
nor As(V) affected the repair of H2O2-induced DNA dam-
age suggests that BER in the urinary bladder transitional
cells was not significantly affected by 100 ppm of these
arsenicals. Alternatively, effects on the BER pathway
could be transitory and thus not seen in cells removed
and treated in vitro with DNA damaging agents in our
study. It is also possible that DNA repair in urinary blad-
der transitional cells is only affected by a longer-term ex-
posure to arsenic than the 1-week exposure in this study.
Similarly, formaldehyde-induced DNA-protein crosslinks
are believed to be removed partially by spontaneous hy-
drolysis [Quievryn and Zhitkovich, 2000] and by NER,
proteasome-assisted proteolysis followed by NER, or ho-
mologous recombination repair with NER components
[Barker et al., 2005]. Although both DMA(V) and its
metabolite, DMA(III), decreased NER in a cultured
human lung carcinoma cell line, A549 cells [Schwerdtle
et al., 2003], in our study DMA(V) exposure through
drinking water did not affect the in vitro repair or forma-
tion of formaldehyde-induced DNA-protein crosslinks in
urinary bladder transitional cells.
In Schwerdtle’s study [Schwerdtle et al., 2003], A549
cells were exposed to DMA(V) for 16 hr, and then to
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(1)-antibenzo[a]pyrene-7,8-diol 9,10-epoxide (BPDE) for
2 hr, followed by 8 hr of recovery in the presence of
DMA(V). The repair of BPDE-DNA adducts was
decreased at 250 lM DMA(V). Meanwhile, 30 min expo-
sure to 10 mM DMA(V) caused only a slight increase in
zinc release from synthesized XPA peptide (XPAzf) rep-
resenting the zinc finger domain from xeroderma pigmen-
tosum group A protein (XPA, a human zinc finger pro-
tein, involved in the recognition/incision step of NER),
and no effect on the repair activity of isolated Fpg protein
(an Escherichia coli zinc finger protein, involved in ini-
tiating BER). It cannot be ruled out that NER compo-
nent(s) responsible for observed decreased NER in A459
cells were not involved in the removal of DNA-protein
crosslinks, which could contribute to the lack of inhibition
of DNA-protein crosslinks seen in our study. Compared
to our study [100 ppm (0.72 lM) DMA(V) in water for 1
week and recovery for 24 hr in the absence of DMA(V)],
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Fig. 4. The frequencies of MN in bone marrow were not affected by 7-
day exposures to DMA(V) or As(V) through drinking water. CP (posi-
tive control, Group E) and DMA(V)1CP exposures (Group A) signifi-
cantly increased MN frequencies as compared to tap water exposure
(negative control, Groups G and H). The MN frequencies were not sig-
nificantly different among rats exposed to CP and DMA(V)1CP, indicat-
ing that DMA(V) did not enhance CP effects in inducing MN. The MN
frequencies were also not significantly different among rats exposed to
DMA(V) (Group C), As(V) (Group I) and tap water, demonstrating that
neither DMA(V) nor As(V) increased MN. * indicates a significant dif-
ference from negative controls [rats exposed to tap water (Groups G and
H)]. [Color figure can be viewed in the online issue, which is available
at www.interscience.wiley.com.]
Fig. 5. Erythrocyte production was not affected by 7-day exposure to
DMA(V) or As(V) in drinking water. Exposures to CP (positive control,
Group E) and DMA(V)1CP (Group A) significantly decreased polychro-
matic erythrocyte percentages as compared to tap water exposure (nega-
tive control, Groups G and H), and the polychromatic erythrocyte per-
centages were not significantly different between CP and DMA(V)1CP
exposures, suggesting that DMA(V) did not augment CP-induced
decreases in erythrocyte production. The polychromatic erythrocyte per-
centages were not significantly different among rats exposed to DMA(V)
(group C), As(V) (Group I) and tap water(Groups G and H), showing
that neither DMA(V) nor As(V) decreased erythrocyte production. *
indicates a significant difference from negative controls [rats exposed to
tap water (Groups G and H)]. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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Schwerdtle’s study used a much shorter exposure of a
higher concentration of DMA(V) [16 hr of exposure to
250 lM DMA(V), and then 8 hr recovery in the presence
of DMA(V)]. When female F344 rats were given 100
ppm DMA(V) in water for 14 days, dimethylated arseni-
cals were 10 ppm in urine and less than 1 ppm in uri-
nary bladder, while trimethylated arsenicals were higher
than 90 ppm in urine and approximate 3 ppm in urinary
bladder [Adair et al., 2007]. This suggested that urinary
bladder cells were exposed to significantly less than 100
ppm DMA(V) in our study. While out study did not show
inhibition of DNA repair, it does not necessarily contra-
dict Schwerdtle’s study (2003).
In rats and mice, DNA single strand breaks were
increased in the lung after an oral gavage of DMA(V) at a
higher than LD50 dose, and the DNA damage was repaired
within 24 hr after the gavage [Yamanaka et al., 1989]. In
cultured bladder cells, As(V) and DMA(V) were the least
potent in inducing DNA damage among six trivalent and
pentavalent arsenicals [Wang et al., 2007b]. In the present
study, urinary bladder transitional cells collected from rats
1 day after 1-week exposure to DMA(V) or As(V) did not
show increases in DNA damage. In studies by Cohen et al.
[2001], increased necrosis and exfoliation in the urothe-
lium were observed under scanning electron microscope
after 1-week exposure to 100 ppm DMA(V), and necrotic
and exfoliated (severely damaged or dead) cells may have
more DNA damage than healthy cells. It is plausible that
our data reflected either a recovery from DMA(V)-induced
DNA damage within 24 hr through DNA repair or loss of
heavily damaged cells via exfoliation.
The effects of arsenic on the MN frequency depend on
the arsenic species and exposure doses. Inorganic arsenic
in drinking water [a mixture of As(III) and As(V)]
increased MN frequencies in various tissues/cells of
humans (exfoliated bladder cells in China [Tian et al.,
2001], Chile [Moore et al., 1997], India [Basu et al.,
2004], and USA [Warner et al., 1994]; buccal mucosal
cells in China [Feng et al., 2001; Tian et al., 2001] and
India [Chakraborty et al., 2006]; airway epithelial cells in
sputum in China [Tian et al., 2001]). In these studies, the
concentrations of arsenic in water in exposed or high ex-
posure groups ranged from 66.75 lg/l [Chakraborty et al.,
2006], 215 lg/l [Basu et al., 2004] to 500–1000 lg/l
[Feng et al., 2001; Moore et al., 1997; Tian et al., 2001]
or even above 1.3 mg/l [Warner et al., 1994], and the ar-
senic concentrations in low exposure or control ranged
from 15 lg/l to no exposure. As(III) increased bone mar-
row MN frequencies in mice that received As(III) at 50
mg/l in drinking water for 7 days [Lewinska et al., 2007]
and rats that were intraperitoneally injected with As(III)
at 5–20 mg /kg body weight /day for 5 days [Patlolla and
Tchounwou, 2005; Lewinska et al., 2007], but the fre-
quency of MN was not increased by As(V) in mice
exposed to 50, 200 or 500 lg As(V)/l in water for 12
months [Palus et al., 2006]. The effects of DMA(V) on
MN were only previously studied in vitro, and DMA(V)
did not increase MN frequency after exposure at 5 mM
for 1 hr, 10 times the cytotoxic concentration (500 lM
for 1 hr), in Chinese hamster ovary (CHO-9) cells [Dopp
et al., 2004]. Although rats show a higher tolerance to ar-
senic toxicity and higher arsenic (namely DMA(III)) bind-
ing to red blood cells than humans, rats are still consid-
ered a good animal model for arsenic toxicity/carcinoge-
nicity studies [Sams et al., 2007]. Furthermore, F344 rats
are the only laboratory animals which have shown
arsenic-induced urinary bladder cancer. Our finding, in
which neither As(V) nor DMA(V) exposure through
drinking water increased MN frequency in rat bone mar-
row, is consistent with previous reports.
The arsenic species that directly induce MN are not
clear. Dopp et al. [2004] showed that MN were induced
in Chinese hamster ovary (CHO) cells in vitro by
DMA(III) and MMA(III), but not by inorganic arsenic,
MMA(V), or DMA(V). However, injections of dimethy-
larsinous iodide, which is presumed to form DMA(III) by
hydrolysis in aqueous solution, did not increase MN in
mouse peripheral blood [Kato et al., 2003]. Additionally,
while neither DMA(V) nor dimethylarsinous iodide injec-
tions increased MN frequencies, MN frequencies were
increased by coinjections of either (1) DMA(V) and
reduced glutathione (GSH) or (2) dimethylarsinous iodide
and GSH [Kato et al., 2003]. Because dimethylarsine was
observed when DMA(V) and GSH were present, the
authors suggested free radicals generated from the reac-
tion of dimethylarsine with molecular oxygen, and not
DMA(III) itself, may be the direct cause of MN.
In summary, F344 rats exposed to 100 ppm DMA(V)
or As(V) in the drinking water for 1 week did not show
alterations in the sensitivity to CP- or formaldehyde-
induced DNA damage, or in the repair of H2O2-induced
DNA damage in urinary bladder transitional cells. Neither
DMA(V) nor As(V) exposure increased MN frequencies
in the bone marrow, and DMA(V) did not increase CP-
induced MN. Other mechanisms, such as oxidative stress,
increases in cell proliferation, and alteration in metabo-
lism of other chemicals, may contribute to arsenic carci-
nogenesis/cocarcinogenesis in the urinary bladder. It also
cannot be ruled out that longer exposures to lower con-
centrations of arsenic, closer to human exposure condi-
tions than our 1 week exposure study, may cause DNA
repair inhibition in urinary bladder transitional cells.
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